In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model.
about
Integrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive TreatmentPharmacokinetics of linezolid treatment using intravenous and oral administrations in extremely premature infants.In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureusComparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus.Linezolid in prophylaxis against experimental aortic valve endocarditis due to Streptococcus oralis or Enterococcus faecalis.Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections.Pharmacokinetics and pharmacodynamics of antibacterial agents.Internal device decreases antibiotic's efficacy on experimental osteomyelitis.Novel concentration-killing curve method for estimation of bactericidal potency of antibiotics in an in vitro dynamic model.Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones.In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus.Linezolid bladder irrigation as adjunctive treatment for a vancomycin-resistant Enterococcus faecium catheter-associated urinary tract infection.Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.In vivo activity of a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, ceftaroline, against vancomycin-susceptible and -resistant Enterococcus faecalis strains in a rabbit endocarditis model: a comparative study with linezolid aPharmacokinetic/pharmacodynamic factors influencing emergence of resistance to linezolid in an in vitro model.Successful treatment of Staphylococcus epidermidis hip prosthesis infection with oral linezolid.Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.Optimization of linezolid therapy in the critically ill: the effect of adjusted infusion regimens.Systemic Moxifloxacin in Streptococcus viridans Endophthalmitis.
P2860
Q28551361-0A15F759-623C-4281-B43A-ED3700532078Q33420904-630A73BB-D794-419D-962A-D5E1174B97E4Q33556476-6AB71EDA-EF44-4E26-A06C-427DB83488ABQ34090666-82AA56AD-81B2-4CF4-866D-D3E54A4DDDF7Q34352123-A7F44639-B09C-489B-B429-506E08107833Q36777850-0AD40900-0B81-43C4-B96D-2EF7999F6F90Q36911111-D4D7998A-9D83-44C4-891F-3C5AAD9C3DF9Q37131126-E6675813-CDEB-4570-B852-9D89547C93C1Q37568944-E9D586CA-2E95-4667-9568-16CB029A802AQ37625071-D2E4048A-18CA-4B28-A0EB-B07D32CD080AQ38777085-56CC2F21-D933-4159-88EC-6A603B5A9DB7Q41474175-6E9BAA6B-6D58-4849-A55D-879EC855EC32Q41595514-A876411D-E6B5-42FC-AEEE-10BDF1CC7ED2Q42027484-59AF7225-57D4-4EA8-BA43-67AA67C9F1F0Q42627381-5B9D0C16-D269-4DCB-A6DD-08BD9A4E0436Q42687422-A6C78B01-5EF4-4704-8363-C33DFA402D56Q42846091-8865D217-B288-405A-850F-8784E8B14966Q44869556-4FA0B673-29DE-4126-84EB-2CA981112D76Q47611899-0F314924-EDEB-4F9B-8B01-0054EEDB4159Q47881654-6FFEF6B5-2BF3-4151-974E-3B85DA20F0ACQ49581179-B8C06526-8F92-4874-B97A-DC79E931DD0F
P2860
In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
In vivo efficacy of continuous ...... eus rabbit endocarditis model.
@ast
In vivo efficacy of continuous ...... eus rabbit endocarditis model.
@en
In vivo efficacy of continuous ...... eus rabbit endocarditis model.
@nl
type
label
In vivo efficacy of continuous ...... eus rabbit endocarditis model.
@ast
In vivo efficacy of continuous ...... eus rabbit endocarditis model.
@en
In vivo efficacy of continuous ...... eus rabbit endocarditis model.
@nl
prefLabel
In vivo efficacy of continuous ...... eus rabbit endocarditis model.
@ast
In vivo efficacy of continuous ...... eus rabbit endocarditis model.
@en
In vivo efficacy of continuous ...... eus rabbit endocarditis model.
@nl
P2093
P2860
P1476
In vivo efficacy of continuous ...... reus rabbit endocarditis model
@en
P2093
Antoine Hamel
David Boutoille
Denis Bugnon
Gilles Potel
Jocelyne Caillon
Lucia Perez
Marie-France Kergueris
P2860
P304
P356
10.1128/AAC.46.12.3706-3711.2002
P407
P577
2002-12-01T00:00:00Z